| 1 |
33796223 | A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas. | 2021 Mar 16 |
1 |
| 2 |
33984442 | Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women. | 2021 Jul 30 |
1 |
| 3 |
34202736 | Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell Lines. | 2021 Jun 24 |
2 |
| 4 |
31492752 | Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex. | 2019 Oct 11 |
1 |
| 5 |
29662081 | A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells. | 2018 Apr 16 |
1 |
| 6 |
26794656 | Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cells. | 2016 Jan 21 |
1 |
| 7 |
18528468 | Warts, cancer and ubiquitylation: lessons from the papillomaviruses. | 2006 |
1 |
| 8 |
9497376 | The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. | 1998 Mar 13 |
1 |
| 9 |
7845670 | The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain. | 1995 Feb 2 |
1 |